International Business Machines CORP Form 4 insider transactions
NYSE
IBM director Frederick William McNabb III acquired 396 shares of common stock through a deferred compensation plan.
NYSE
IBM director Michael Miebach acquired 396 shares of common stock through a deferred compensation plan.
NYSE
An IBM director has deferred a portion of their fees into Promised Fee Shares, payable upon retirement, as part of the company's compensation plan.
NYSE
IBM director Peter R. Voser acquired 430 shares of common stock through a deferred compensation plan.
NYSE
IBM director Frederick H. Waddell acquired 419 shares of common stock through a deferred compensation plan.
NYSE
IBM director Alfred W. Zollar acquired 396 shares of common stock through a deferred compensation plan.
NYSE
IBM Senior Vice President Jaclyn LaMoreaux reports the vesting of restricted stock units and subsequent sale of shares to cover taxes.
NYSE
IBM's VP, Controller, Nicolas Fehring, reported multiple transactions involving company stock, including the vesting of restricted stock units and the disposal of shares to cover tax obligations.
NYSE
IBM's Senior Vice President and CFO, James J. Kavanaugh, acquired 88 phantom stock units under the company's Excess Savings Plan.
NYSE
IBM CEO Arvind Krishna acquired 165 phantom stock units through the company's Excess Savings Plan, which will convert to cash upon separation from the company.
NYSE
IBM Senior Vice President Robert David Thomas acquired one phantom stock unit under the company's Excess Savings Plan.
NYSE
IBM Senior Vice President Anne Robinson reported the acquisition of restricted stock units and employee stock options on July 1, 2024.
NYSE
IBM director Marianne Brown acquired 506 shares of common stock through a deferred compensation plan.
NYSE
IBM director Thomas Buberl acquired 506 shares of common stock through a deferred compensation plan.
NYSE
IBM director David N. Farr acquired 319 shares of common stock through a deferred compensation plan on June 28, 2024.
NYSE
IBM director Alex Gorsky acquired 579 shares of common stock through a deferred compensation plan.
NYSE
IBM director Michelle J. Howard acquired 456 shares of common stock through a deferred compensation plan.
NYSE
IBM director Andrew Liveris acquired 535 shares of common stock through a deferred compensation plan.
NYSE
IBM director Frederick William McNabb III acquired 506 shares of common stock through a deferred compensation plan.
NYSE
IBM Director Michael Miebach acquired 506 shares of common stock through a deferred compensation plan.
NYSE
IBM director Martha E. Pollack acquired 319 shares of common stock through a deferred compensation plan.
NYSE
IBM director Peter R. Voser acquired 550 shares of common stock through a deferred compensation plan.
NYSE
IBM director Frederick H. Waddell acquired 535 shares of common stock through a deferred compensation plan.
NYSE
IBM director Alfred W. Zollar acquired 506 shares of common stock through a deferred compensation plan.
NYSE
IBM's Senior VP and CFO, James Kavanaugh, reported the vesting of restricted stock units and subsequent transactions involving IBM common stock on June 8, 2024.
NYSE
IBM CEO Arvind Krishna reported the vesting and subsequent sale of restricted stock units (RSUs) on June 8, 2024, resulting in changes to his beneficial ownership of company stock.
NYSE
IBM Senior Vice President Jaclyn Lamoreaux exercised stock options and sold shares on June 8, 2024, according to a recent SEC filing.
NYSE
IBM Senior Vice President Michelle Browdy reported the vesting and subsequent sale of restricted stock units on June 8, 2024.
NYSE
IBM's VP, Controller, Nicolas Fehring, reported multiple transactions involving the company's common stock and restricted stock units.
NYSE
IBM Senior Vice President Robert David Thomas reported multiple transactions involving company stock, including the vesting of restricted stock units and a transfer of shares to a family trust.